...
首页> 外文期刊>Journal of cataract and refractive surgery >Laser in situ keratomileusis: ablation on the flap and stromal bed in a primary treatment.
【24h】

Laser in situ keratomileusis: ablation on the flap and stromal bed in a primary treatment.

机译:激光原位角膜磨镶术:主要治疗方法是切除皮瓣和基质床。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To analyze outcomes of laser in situ keratomileusis (LASIK) performed on the flap and on the stromal bed at the same time in a primary treatment. SETTING: Instituto de la Vision, Buenos Aires, Argentina. METHODS: Twenty-two cases (13 female, 9 male) were studied retrospectively; the mean age of the patients was 33.15 years +/- 10.44 (SD). Inclusion criteria were low pachymetry or topographic asymmetry. Twenty cases (90.9%) presented with low pachymetry (512.2 +/- 21.40 mum), and 2 cases (9.1%) presented with topographic asymmetry (inferior-superior difference more than 1.5 diopters [D]). Ablation was performed on the flap from the back and on the bed. The flap was made using the Technolas Hansatome microkeratome and the ablation by the Technolas 217z excimer laser (both by Bausch & Lomb). Preoperatively, the spherical equivalent (SE) was -5.61 +/- 1.72 D, the cylinder was -1.78 +/- 1.24 D, and the best spectacle-corrected visual acuity (BSCVA) was 0.77 +/- 0.19. Difficulties and complications of the technique, efficacy and safety index, and aberrations were analyzed. RESULTS: According to the surgical plan and our nomogram, diopters corrected on the flap were -1.73 +/- 1.08 and on the bed were -4.77 +/- 1.89. The mean follow-up was 8.28 +/- 2.19 months. At 6 months, the SE was -0.21 +/- 0.39, vectorial change was 1.69 +/- 0.74, and the BSCVA was 0.77 +/- 0.20. Postoperatively, no eye had an increase in refractive astigmatism. Uncorrected visual acuity was 20/40 or better in all cases (100%) and 20/25 or better in 13 cases (59.1%). Regarding gained and lost lines of BSCVA, 54.5% conserved the lines, 18.2% lost 1 line, 9.1% gained 1 line, and 18.2% gained 2 lines. CONCLUSIONS: Simultaneous ablation on the flap and on the bed in cases of low pachymetry or topographical asymmetry was predictable, effective, and safe.
机译:目的:分析在主要治疗中同时在皮瓣和基质床上进行的激光原位角膜磨镶术(LASIK)的结果。地点:阿根廷布宜诺斯艾利斯视觉研究所。方法:回顾性分析22例(女性13例,男性9例)。患者的平均年龄为33.15岁+/- 10.44(SD)。纳入标准为低测厚法或地形不对称。 20例(90.9%)表现为低测厚法(512.2 +/- 21.40 mum),2例(9.1%)表现为地形不对称(上下差异大于1.5屈光度[D])。从背部和床上对皮瓣进行消融。皮瓣使用Technolas Hansatome微型角膜刀制成,并通过Technolas 217z准分子激光(均由Bausch&Lomb研制)进行消融。术前,当量球镜当量(SE)为-5.61 +/- 1.72 D,圆柱体为-1.78 +/- 1.24 D,最佳眼镜矫正视力(BSCVA)为0.77 +/- 0.19。分析了该技术的难点和并发症,疗效和安全性指标以及像差。结果:根据手术计划和我们的诺模图,皮瓣矫正的屈光度为-1.73 +/- 1.08,床上矫正的屈光度为-4.77 +/- 1.89。平均随访时间为8.28 +/- 2.19个月。在6个月时,SE为-0.21 +/- 0.39,矢量变化为1.69 +/- 0.74,BSCVA为0.77 +/- 0.20。术后,没有眼睛屈光散光增加。未经矫正的视力在所有情况下均为20/40或更高(100%),在13例情况下为20/25或更高(59.1%)。关于BSCVA的增减线,保留线占54.5%,丢失1条线占18.2%,获得1条线占9.1%,获得2条线占18.2%。结论:在低测厚法或地形不对称情况下,皮瓣和床同时消融是可预测,有效和安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号